The last two years have seen tremendous growth with $70 billion of private equity capital and public National Institutes of Health (NIH) funding pouring into life sciences-related companies in North America in 2020 and a record $78 billion in 2021.
This Q1 2022 Life Sciences Update breaks down the current trends in the life sciences industry at a high level by exploring:
- Where the capital is flowing;
- Where the talent can be found; and
- The impact on the lab space market (i.e., demand, cost and new construction).
Additional markets covered also include:
Select each tab below for a preview of highlighted insights featured in the full report.